Webster, Jacqui
Waqa, Gade
Thow, Anne-Marie
Allender, Steven
Lung, Thomas
Woodward, Mark
Rogers, Kris
Tukana, Isimeli
Kama, Ateca
Wilson, Donald
Mounsey, Sarah
Dodd, Rebecca
Reeve, Erica
McKenzie, Briar Louise
Johnson, Claire
Bell, Colin
Funding for this research was provided by:
National Health and Medical Research Council (APP1169322)
National Heart Foundation of Australia (APP102039)
Article History
Received: 16 September 2020
Accepted: 19 January 2022
First Online: 2 February 2022
Declarations
:
: Due to the adaptive, responsive nature of this project, ethics approvals will be obtained in different stages. Ethics approval for the policy landscape analysis has been obtained from the Human Research Ethics Committee at the University of New South Wales (HC200055) and the College Health Research Ethics Committee (CHREC) of FNU in Fiji (184.20). Approvals for the other aspects will be obtained as appropriate from the Human Research Ethics Committee at the University of New South Wales, University of Sydney and/or Deakin University in Australia, and from the local ethics committees in Fiji (CHREC) of FNU and Samoa (Ministry of Health). Informed consent will be obtained for participation in the community surveys and stakeholder interviews.
: Not applicable.
: MW is a consultant for Amgen and Kirin. No other conflicts of interests declared.